本页面由Tiger Trade Technology Pte. Ltd.提供服务

Madrigal Pharmaceuticals, Inc.

467.16
-4.5900-0.97%
盘后:467.160.00000.00%19:30 EDT
成交量:46.93万
成交额:2.19亿
市值:107.71亿
市盈率:-32.86
高:478.85
开:471.75
低:460.22
收:471.75
52周最高:615.00
52周最低:393.61
股本:2,305.55万
流通股本:1,372.50万
量比:1.54
换手率:3.42%
股息:- -
股息率:- -
每股收益(TTM):-14.2164
每股收益(LYR):-12.8501
净资产收益率:-53.31%
总资产收益率:-17.84%
市净率:20.57
市盈率(LYR):-36.35

数据加载中...

2026/09/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/12

重要事件披露

Form 8-K - Current report
2026/07/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/30

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/17

重要事件披露

Form 8-K - Current report
2026/06/17

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/04/28

重要事件披露

Form 8-K - Current report
2026/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities